Bayer (BAYG)

53.33 -0.81 (-1.50%)
Closed EUR Disclaimer
Industry
Pharmaceuticals
Sector
Healthcare
Employees
95950
Equity Type
ORD
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Contact Information
Address
Leverkusen,51368 Germany
Phone
49 214 30 1
Fax
-
Top Executives
Name
Age
Since
Title
Norbert Winkeljohann 64 2018 Independent Chairman of Supervisory Board
Daniel Hartert 63 0000 Chairman of Executive Board - Bayer Business Services
Günter Hilken 67 0000 Chairman of Executive Board - Currenta
Heike Hausfeld 57 2017 Vice Chairman of Supervisory Board
Andrea Sacher 41 2020 Member of Supervisory Board
Michael Westmeier 50 2022 Employee Representative Member of the Supervisory Board
Fei-Fei Li 46 2021 Independent Member of the Supervisory Board
Alberto Weisser 67 2021 Independent Supervisory Board Member
Francesco Grioli 50 2022 Employee Representative Member of the Supervisory Board
Claudia Schade 44 2022 Employee Representative Supervisory Board Member
Barbara Gansewendt 0 2022 Employee Representative Supervisory Board Member
André van Broich 52 2012 Member of Supervisory Board
Simone Bagel-Trah 53 2014 Independent Member of Supervisory Board
Otmar D. Wiestler 66 2014 Independent Member of Supervisory Board
Colleen A. Goggins 68 2017 Independent Member of Supervisory Board
Ertharin Cousin 65 2019 Independent Member of the Supervisory Board
Paul M. L. Achleitner 66 2002 Member of Supervisory Board
Heinz Georg Webers 63 2022 Employee Representative Member of Supervisory Board
Norbert W. Bischofberger 66 2017 Independent Member of Supervisory Board
Horst Baier 66 2020 Independent Member of Supervisory Board
Reiner Hoffmann 67 2006 Member of Supervisory Board
Frank Löllgen 61 2015 Member of Supervisory Board
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.